169 related articles for article (PubMed ID: 24138328)
1. Invasive fungal infections in lymphoproliferative disorders: a monocentric retrospective experience.
Nosari AM; Pioltelli ML; Riva M; Marbello L; Nichelatti M; Greco A; Molteni A; Vismara E; Gabutti C; Volonterio A; Lombardi P; Morra E
Leuk Lymphoma; 2014 Aug; 55(8):1844-8. PubMed ID: 24138328
[TBL] [Abstract][Full Text] [Related]
2. Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections.
Nosari AM; Caira M; Pioltelli ML; Fanci R; Bonini A; Cattaneo C; Castagnola C; Capalbo SF; De Fabritiis P; Mettivier V; Morselli M; Pastore D; Aversa F; Rossi G; Pagano L;
Clin Microbiol Infect; 2013 Aug; 19(8):757-62. PubMed ID: 23279327
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients.
Cesaro S; Tridello G; Castagnola E; Calore E; Carraro F; Mariotti I; Colombini A; Perruccio K; Decembrino N; Russo G; Maximova N; Baretta V; Caselli D
Eur J Haematol; 2017 Sep; 99(3):240-248. PubMed ID: 28556426
[TBL] [Abstract][Full Text] [Related]
4. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
[TBL] [Abstract][Full Text] [Related]
5. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.
Kurosawa M; Yonezumi M; Hashino S; Tanaka J; Nishio M; Kaneda M; Ota S; Koda K; Suzuki N; Yoshida M; Hirayama Y; Takimoto R; Torimoto Y; Mori A; Takahashi T; Iizuka S; Ishida T; Kobayashi R; Oda T; Sakai H; Yamamoto S; Takahashi F; Fukuhara T
Int J Hematol; 2012 Dec; 96(6):748-57. PubMed ID: 23111539
[TBL] [Abstract][Full Text] [Related]
7. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.
Auberger J; Lass-Flörl C; Ulmer H; Nogler-Semenitz E; Clausen J; Gunsilius E; Einsele H; Gastl G; Nachbaur D
Int J Hematol; 2008 Dec; 88(5):508-515. PubMed ID: 18982251
[TBL] [Abstract][Full Text] [Related]
8. Invasive Fungal Infections After Kidney Transplantation: A Single-center Experience.
Santos T; Aguiar B; Santos L; Romaozinho C; Tome R; Macario F; Alves R; Campos M; Mota A
Transplant Proc; 2015 May; 47(4):971-5. PubMed ID: 26036497
[TBL] [Abstract][Full Text] [Related]
9. Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients.
Silveira FP; Kwak EJ; Paterson DL; Pilewski JM; McCurry KR; Husain S
J Heart Lung Transplant; 2008 Aug; 27(8):850-5. PubMed ID: 18656797
[TBL] [Abstract][Full Text] [Related]
10. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
Pagano L; Caira M; Candoni A; Offidani M; Fianchi L; Martino B; Pastore D; Picardi M; Bonini A; Chierichini A; Fanci R; Caramatti C; Invernizzi R; Mattei D; Mitra ME; Melillo L; Aversa F; Van Lint MT; Falcucci P; Valentini CG; Girmenia C; Nosari A
Haematologica; 2006 Aug; 91(8):1068-75. PubMed ID: 16885047
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
12. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
[TBL] [Abstract][Full Text] [Related]
13. Invasive mold infections: recent advances in management approaches.
Chandrasekar P
Leuk Lymphoma; 2009 May; 50(5):703-15. PubMed ID: 19337880
[TBL] [Abstract][Full Text] [Related]
14. Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006.
Hahn-Ast C; Glasmacher A; Mückter S; Schmitz A; Kraemer A; Marklein G; Brossart P; von Lilienfeld-Toal M
J Antimicrob Chemother; 2010 Apr; 65(4):761-8. PubMed ID: 20106864
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology.
des Champs-Bro B; Leroy-Cotteau A; Mazingue F; Pasquier F; François N; Corm S; Lemaitre L; Poulain D; Yakoub-Agha I; Alfandari S; Sendid B
J Clin Pharm Ther; 2011 Apr; 36(2):152-60. PubMed ID: 21366643
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients.
El-Mahallawy HA; Shaker HH; Ali Helmy H; Mostafa T; Razak Abo-Sedah A
Med Mycol; 2006 Dec; 44(8):733-9. PubMed ID: 17127630
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies.
Hoenigl M; Zollner-Schwetz I; Sill H; Linkesch W; Lass-Flörl C; Schnedl WJ; Krause R
Mycoses; 2011 Sep; 54(5):454-9. PubMed ID: 20406398
[TBL] [Abstract][Full Text] [Related]
19. Current challenges in the management of invasive fungal infections.
Lai CC; Tan CK; Huang YT; Shao PL; Hsueh PR
J Infect Chemother; 2008 Apr; 14(2):77-85. PubMed ID: 18622668
[TBL] [Abstract][Full Text] [Related]
20. Distribution of invasive fungal infections: Molecular epidemiology, etiology, clinical conditions, diagnosis and risk factors: A 3-year experience with 490 patients under intensive care.
Borjian Boroujeni Z; Shamsaei S; Yarahmadi M; Getso MI; Salimi Khorashad A; Haghighi L; Raissi V; Zareei M; Saleh Mohammadzade A; Moqarabzadeh V; Soleimani A; Raeisi F; Mohseni M; Mohseni MS; Raiesi O
Microb Pathog; 2021 Mar; 152():104616. PubMed ID: 33212195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
